Evidence map›Paper›PMID 29221465›Full record

ArticleHuman genomics2017

Yale school of public health symposium on lifetime exposures and human health: the exposome; summary and future reflections.

Caroline H Johnson, Toby J Athersuch, Gwen W Collman, Suraj Dhungana, David F Grant, Dean P Jones, Chirag J Patel, Vasilis Vasiliou

Abstract readConference Proceedings
In one paragraph

Article in Human genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. The alcohol exposome.Alcohol (Fayetteville, N.Y.) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caroline H JohnsonDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA. caroline.johnson@yale.edu.
Toby J AthersuchDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Gwen W CollmanDivision of Extramural Research and Training, National Institute of Environmental Health Sciences, National Institutes of Health, Morrisville, NC, USA.
Suraj DhunganaWaters Corporation, Metabolomics and Translational Research, Milford, MA, USA.
David F GrantDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
Dean P JonesDepartment of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Chirag J PatelDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Vasilis VasiliouDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA. vasilis.vasiliou@yale.edu.

Funding

Pilot Project ProgramP30ES019776 · NIEHS · EMORY UNIVERSITY · PI Carmen Joseph Marsit · 2013 to 2026
$22.6M
National Exposure Assessment Laboratory at EmoryU2CES026560 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2015 to 2015
$8.3M
Mouse Models for Alcohol Metabolism and Tissue InjuryR24AA022057 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2013 to 2022
$4.5M
Novel Role of Corneal Crystallins as Modulators of Cell Growth and TransparencyR01EY017963 · NEI · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2007 to 2019
$3.7M
Cytoplasmic-nuclear redox signaling: Disruption by dietary cadmium levelsR01ES023485 · NIEHS · EMORY UNIVERSITY · PI GO KANG, YOUNG-MI, JONES, DEAN PAUL · 2014 to 2018
$1.8M
The role of ALDH1B1 in ethanol metabolism and colon cancerU01AA021724 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2014 to 2017
$1.7M
Data-driven identification of environmental factors in cardiovascular diseaseR00ES023504 · NIEHS · HARVARD MEDICAL SCHOOL · PI PATEL, CHIRAG J. · 2016 to 2018
$728k
Orbitrap Elite/H-ESI BundleS10OD018006 · OD · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2014 to 2014
$600k
Mitochondria Environmental Stress Signaling NetworksR21ES025632 · NIEHS · EMORY UNIVERSITY · PI GO KANG, YOUNG-MI, JONES, DEAN PAUL · 2015 to 2017
$576k
Increasing the power of GxE detection by using multi-locus genome-wide predictorsR21ES025052 · NIEHS · HARVARD MEDICAL SCHOOL · PI PATEL, CHIRAG J. · 2015 to 2017
$434k
National Eye Institute R01 EY017963National Institute of Environmental Health Sciences P30 ES019776National Institute of Environmental Health Sciences R00 ES023504National Institute of Environmental Health Sciences R01 ES023485National Institute of Environmental Health Sciences R21 ES025052National Institute of Environmental Health Sciences R21 ES025632National Institute of Environmental Health Sciences U2C ES026560National Institute on Alcohol Abuse and Alcoholism R24 AA022057National Institute on Alcohol Abuse and Alcoholism U01 AA021724NEI NIH HHS R01 EY017963NIAAA NIH HHS R24 AA022057NIAAA NIH HHS U01 AA021724NIEHS NIH HHS P30 ES019776NIEHS NIH HHS R00 ES023504NIEHS NIH HHS R01 ES023485NIEHS NIH HHS R21 ES025052NIEHS NIH HHS R21 ES025632NIEHS NIH HHS U2C ES026560NIH HHS S10 OD018006NIH Office of the Director S10 OD018006
6 · The paper itself

Abstract

The exposome is defined as "the totality of environmental exposures encountered from birth to death" and was developed to address the need for comprehensive environmental exposure assessment to better understand disease etiology. Due to the complexity of the exposome, significant efforts have been made to develop technologies for longitudinal, internal and external exposure monitoring, and bioinformatics to integrate and analyze datasets generated. Our objectives were to bring together leaders in the field of exposomics, at a recent Symposium on "Lifetime Exposures and Human Health: The Exposome," held at Yale School of Public Health. Our aim was to highlight the most recent technological advancements for measurement of the exposome, bioinformatics development, current limitations, and future needs in environmental health. In the discussions, an emphasis was placed on moving away from a one-chemical one-health outcome model toward a new paradigm of monitoring the totality of exposures that individuals may experience over their lifetime. This is critical to better understand the underlying biological impact on human health, particularly during windows of susceptibility. Recent advancements in metabolomics and bioinformatics are driving the field forward in biomonitoring and understanding the biological impact, and the technological and logistical challenges involved in the analyses were highlighted. In conclusion, further developments and support are needed for large-scale biomonitoring and management of big data, standardization for exposure and data analyses, bioinformatics tools for co-exposure or mixture analyses, and methods for data sharing.

Indexed as

Environmental ExposureEnvironmental HealthEnvironmental MonitoringHumansPublic HealthSocieties, Scientific

Identifiers

PMID29221465
PMCPMC5723043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.